IRIS
LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.742
EU - Europa 1.192
AS - Asia 941
AF - Africa 192
SA - Sud America 49
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.721
CN - Cina 425
SG - Singapore 417
FI - Finlandia 337
IE - Irlanda 238
NG - Nigeria 191
FR - Francia 125
DE - Germania 110
IT - Italia 100
NL - Olanda 80
GB - Regno Unito 52
IN - India 42
SE - Svezia 41
BR - Brasile 30
RU - Federazione Russa 21
MK - Macedonia 19
CA - Canada 16
BE - Belgio 15
PK - Pakistan 15
CL - Cile 10
UA - Ucraina 10
IL - Israele 9
TR - Turchia 9
AR - Argentina 7
AU - Australia 7
CH - Svizzera 6
ES - Italia 6
HU - Ungheria 6
PH - Filippine 6
RO - Romania 6
GR - Grecia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
IR - Iran 3
PL - Polonia 3
AT - Austria 2
EE - Estonia 2
EU - Europa 2
KR - Corea 2
MX - Messico 2
NO - Norvegia 2
PA - Panama 2
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
IS - Islanda 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.129
Salva come PNG Salva come JPEG
Città #
Chandler 1.207
Wilmington 1.051
San Mateo 402
Shanghai 358
Ann Arbor 337
Helsinki 337
Singapore 298
New York 244
Dublin 237
Boardman 206
Lawrence 204
Princeton 204
Benin City 191
Leawood 179
Paris 123
Ashburn 121
Fairfield 87
Woodbridge 82
Amsterdam 59
London 44
Milan 37
Pune 33
Seattle 31
Norwalk 22
Santa Clara 20
Los Angeles 18
San Diego 18
Brussels 15
Lahore 14
Phoenix 13
Toronto 12
Abbiategrasso 9
Falkenstein 9
Kocaeli 9
Skopje 9
Beijing 7
Rome 7
Buenos Aires 6
Hanover 6
Monmouth Junction 6
Mumbai 6
Redmond 6
São Paulo 6
Bitola 5
Clearwater 5
Falls Church 5
Frankfurt am Main 5
Moscow 5
Dronten 4
Houston 4
Madrid 4
Munich 4
Andover 3
Budapest 3
Des Moines 3
Fort Worth 3
Henderson 3
Many 3
Novokuznetsk 3
Olongapo City 3
Pavia 3
Prilep 3
Redwood City 3
Riverview 3
Apo 2
Athens 2
Baoding 2
Belém 2
Bogovinje 2
Brighton 2
Canberra 2
Cesano Boscone 2
Dhaka 2
Eden Prairie 2
Erbusco 2
Florence 2
Gdansk 2
Geneva 2
Genoa 2
Guangzhou 2
Jerusalem 2
Kemerovo 2
Kochi 2
Las Pinas 2
Lincoln 2
Nanjing 2
Nizhniy Novgorod 2
Palazzolo sull'Oglio 2
Portland 2
Puebla 2
Ribeirão Preto 2
Riyadh 2
Sale Marasino 2
San Francisco 2
San Jose 2
Shijiazhuang 2
St Petersburg 2
Tallinn 2
Turi 2
Venegono Superiore 2
Totale 6.439
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 140
A 2019 update on TSH-secreting pituitary adenomas 69
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 68
G protein mutations in endocrine diseases 67
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 63
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 62
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 62
Central hypothyroidism and growth hormone treatment : clinical care 60
Growth factors and human pituitary adenomas 60
G-Protein and Signalling in Pituitary Tumours 59
A potential catastrophic trap: an unusually presenting sellar lesion 59
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 57
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 57
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 57
G protein abnormalities in pituitary adenomas 56
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 55
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 55
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 55
Functional hypothalamic and drug-induced amenorrhea: an overview 54
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 54
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 54
An Unusual Case of Recurrent Autoimmune Hypophysitis 54
Hormonal signaling and pituitary adenomas 52
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 52
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 52
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 52
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 51
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 51
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 51
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 51
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 51
Bone disorders associated with acromegaly: mechanisms and treatment 50
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 50
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 50
Central hypothyroidism 49
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 49
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 49
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 48
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 48
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 48
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 48
Central hypothyroidism - a neglected thyroid disorder 47
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 47
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 47
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 47
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 47
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 46
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 46
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 45
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 45
Genetics of pituitary tumors: Focus on G-protein mutations 45
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 45
cAMP in the pituitary: An old messenger for multiple signals 45
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 45
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 45
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 45
Inactivating and activating mutations of the Gs alpha gene 45
Dopamine D-2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 45
Pituitary incidentalomas 44
GNAS imprinting and pituitary tumors 44
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 44
Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope 44
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 44
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 44
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 44
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 44
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 44
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells 43
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 43
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 43
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 43
Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases 43
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 43
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function 43
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 43
Double Pituitary and Conserved Function in an Adult Patient with Neurofibromatosis Type 1 42
Focus on GH deficiency and thyroid function 42
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 42
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 42
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 42
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 42
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 41
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 41
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 41
GH Response to Oral Glucose Tolerance Test: A Comparison between Patients with Acromegaly and Other Pituitary Disorders 41
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas 41
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 41
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks 41
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 41
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 41
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 41
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 41
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 40
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 40
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 40
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 39
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 39
Mutational analysis of PRKAR1A and Gs alpha in sporadic adrenocortical tumors 39
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase A regulatory subunit 1A protein 39
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 39
Totale 4.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20211.831 6 24 9 15 15 624 252 154 352 173 10 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.821 122 203 333 112 44 269 103 105 48 28 185 269
2024/2025532 66 37 64 64 53 248 0 0 0 0 0 0
Totale 8.320